Top Markets
Coin of the day
Gan & Lee Pharmaceuticals. Gan & Lee Pharmaceuticals.

Gan & Lee Pharmaceuticals.

603087
Pozycja w akcjach #3185
Gan & Lee Pharmaceuticals is a biopharmaceutical enterprise primarily focused... Gan & Lee Pharmaceuticals is a biopharmaceutical enterprise primarily focused on the discovery, development, manufacturing, and marketing of insulin analogues within the Chinese market. Their diverse product portfolio encompasses injectable therapies such as Basalin (an insulin glargine), Prandilin (an insulin lispro), Prandilin 25 (another insulin lispro variant), Raplin (an insulin aspart), Raplin 30 (an insulin aspart 30 formulation), and Similin 30 (an insulin injection). Beyond diabetes treatments, the company also offers various medical devices. Established in 1998, Gan & Lee Pharmaceuticals maintains its corporate headquarters in Beijing, People's Republic of China. The organization underwent a name change in April 2005, transitioning from its former identity as Beijing Gan & Lee Biotechnology Co., Ltd.
Cena akcji
$10.35
Kapitalizacja rynkowa
$6.19B
Zmiana (1 dzień)
3.79%
Zmiana (1 rok)
4.34%
Kraj
CN
Handel Gan & Lee Pharmaceuticals. (603087)

Kategoria

Historia ceny akcji dla Gan & Lee Pharmaceuticals. (603087)
Najwyższa cena zamknięcia: $10.41 dnia 2026-08-01

Najniższa cena zamknięcia: $9.67 dnia 2020-06-01
Historia cen akcji firmy Gan & Lee Pharmaceuticals. od 2020 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 0.64%
2025 49.04%
2024 -17.59%
2023 56.66%
2022 -56.78%
2021 -39.34%
2020 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$371.13 -21.75%
US
$188.78 -39.02%
FR
$161.64 23.75%
JP
$189.94 24.49%
US
$76.37 -5.96%
CH